‘It’s still working’: More are living with cancer as era of targeted drugs takes hold
Advancements in targeted cancer therapies are leading to record survival rates for patients. Personalized medicine, which focuses on specific genetic mutations, is enhancing treatment success and allowing many individuals to live active lives despite their diagnoses. Ongoing research aims to further improve cancer care through comprehensive genomic profiling.
- ▪The American Cancer Society reports that 18 million Americans who have had cancer are currently alive.
- ▪Survival rates for cancer patients have increased significantly, with seven out of ten surviving at least five years.
- ▪Recent studies show a 25 percent drop in cancer deaths among people aged 15 to 49 since 1990.
2 outlets in our directory ran this story. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.
- ▪ ’It’s still working’: More are living with cancer as era of targeted drugs takes hold — Investing.com — News
Straits Times — World files mainly under world. We currently carry 1,485 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Straits Times — World |
| Canonical URL | https://www.straitstimes.com/world/its-still-working-more-are-living-with-cancer-as-era-of-targeted-drugs-takes-hold |
| Publication time | Wed, 03 Jun 2026 20:55:07 +0800 |
| Retrieval time | 2026-06-03T13:02:07.638Z |
| Last seen | 2026-06-03T13:02:07.638Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | zopzxUhHBWI2 · 3 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
‘It’s still working’: More are living with cancer as era of targeted drugs takes holdSign up now: Get ST's newsletters delivered to your inboxMenta “Steve” Wallace and his wife, Jo Linda, at their home in Texas. Menta is taking the experimental pancreatic cancer drug daraxonrasib.PHOTO: REUTERSPublished Jun 03, 2026, 08:55 PMUpdated Jun 03, 2026, 08:59 PMListenSummariseAdvances in targeted drugs and understanding cancer’s genetic basis mean record survival rates.Personalised medicine, targeting specific genetic mutations like HER2 or EGFR, is improving drug success, helping patients overcome resistance and extend life.Cancer patients are living active lives due to these advances.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Straits Times — World.